Does Remdesivir Benefit COVID-19 Patients? A Review of RCTs
In this week’s peer-reviewed update, a meta-analysis of three randomized controlled trials (RCTs) confirms that remdesivir, an antiviral drug originally developed for Ebola, significantly reduces recovery time in hospitalized COVID-19 ... Read More